In another study, overexpressed let-7a inhibited glioma cell malignancy by directly targeting KRAS independently of PTEN [7], and let-7b in turn inhibits malignant behaviour (proliferation, migration and invasion) of glioma cells and stem-like glioma cells [6]. The gene discussed is KRAS; the disease is central nervous system cancer.